LTR Pharma has today announced its Chief Scientific and Clinical Advisor, Professor Eric Chung, has been selected to present at USANZ & ANZUNS 2025 ASM to be hosted in Perth from 1-4 March 2025.
Co-hosted by the Urological Society of Australian and New Zealand (USANZ) and Australia and New Zealand Urological Nurses Society (ANZUNS), this leading industry conference is an important platform for clinical education and networking to support the provision of evidence-based sexual health care.
Professor Chung has been selected to deliver a podium presentation, which will include a detailed examination of clinical data underpinning LTR Pharma’s development stage nasal spray for the treatment of erectile dysfunction (ED), SPONTAN®.
LTR Pharma will also be exhibiting at this event, alongside of Restorative Health Clinic.